3 results
Approved WMORecruiting
The primary objective of the study is to determine the MTD (Maximally Tolerated Dose) of SGN-40 from among three possible dose levels when combined with a standard dose of bortezomib and to determine the safety and adverse event profile for…
Approved WMOCompleted
The goal of this pilot study is to assess the usability and preliminary effects on treatment outcomes of an mHealth application supplementary to SET for patients with intermittent claudication. Furthermore, we aim to determine the reliability,…
Approved WMOCompleted
Aim: To determine the specificity and sensitivity of the AF app to detect AF.